NO. |
Title |
Patent Number |
Authorization Proclamation Date |
Area |
U.S |
||||
1 | CHA Powder-injection and Preparation Method Thereof | US9918956B2 | 2018/3/20 |
Preparation Process |
2 | Uses of CHA in the Preparation of Medicaments for Treatment of Oligodendroglioma | US9884036B2 | 2018/2/6 |
Immune |
3 | Application of CHA and Compositions Thereof in Preparation of Drugs for Treating Squamous Cell Carcinoma | US12194013B2 | 2025/1/14 |
Tumour |
4 | Pharmaceutical Composition and Use Thereof in Preparing Drug for Treating Tumor Multi-drug Resistance | US12178792B2 | 2024/12/31 |
Tumour |
5 | Pharmaceutical Composition for Treating Kidney Cancer and Application Thereof | US12156861B2 | 2024/12/3 |
Tumour |
6 | Use of CHA Composition Thereof in Preparation of Medicament for Treating Sarcoma | US12150926B2 | 2024/11/26 |
Tumour |
7 | Medicine for Combined use in Cancer Treatment | US11628199B2 | 2023/4/18 |
Tumour |
8 | CHA-containing Composition for Nasal Administration | US11596598B2 | 2023/3/7 |
Dosage Form Design |
9 | Use of CHA in Preparation of Drug for Treating Chordoma | US11547715B2 | 2023/1/10 |
Tumour |
10 | Drug Combination for Treatment of Amyotrophic Lateral Sclerosis, Preparation Method and Use Thereof | US11376267B2 | 2022/7/5 |
Rare Diseases |
11 | Use of CHA in Preparing Pharmaceuticals for Treatment of LAG-3-mediated Disease | US11135160B2 | 2021/10/5 |
Tumour |
12 | Preparation Containing CHA Crystal Form and Use Thereof | US10314806B2 | 2019/6/11 | Preparation Process |
13 | Method and Medicines for Treating Melanoma | US10265289B2 | 2019/4/23 |
Tumour |
14 | Crystalline form of CHA and Preparation Method Thereof | US10246401B2 | 2019/4/2 | Preparation Process |
15 | Pharmaceutical Composition, Preparation Method Therefor and Use Thereof | US10238702B2 | 2019/3/26 |
Tumour |
16 | Method for Preparation of Pharmaceutically Acceptable CHA | US10189769B2 | 2019/1/29 | Preparation Process |
17 | Application of CHA in Preparing Medicines for Treating Lupus Erythematosus | US10058525B2 | 2018/8/28 | Immune |
18 | Uses of CHA in the Preparation of Medicaments for Treatment of Oligodendroglioma | US10004713B2 | 2018/6/26 |
Tumour |
Europe |
||||
19 | Use of CHA in Preparing Medicine or Pharmaceutical Composition for Preventing or Treating Pain | EP3909576B1 | 2023/11/15 |
Tumour |
20 | Application of CHA in Preparing Medicines for Treating Lupus Erythematosus | EP3257507B1 | 2025/1/8 | Immune |
21 | Preparation Method for Medicinal CHA | EP3225615B1 | 2020/1/8 | Preparation Process |
22 | Use of CHA in Preparation of Drug Treating Psoriasis | EP3199151B1 | 2020/9/23 | Immune |
23 | Preparation of a Crystalline Form of CHA | EP3141540B1 | 2021/3/3 | Preparation Process |
Japan |
||||
24 |
薬用クロロゲン酸の調製方法 Method for Preparation of Pharmaceutically Acceptable CHA |
JP6488379B2 | 2019/3/20 | Preparation Process |
25 |
杜仲葉からクロロゲン酸を抽出する方法 Method for Extracting CHA from Eucommia Leaves |
JP6473803B2 | 2019/2/20 | Preparation Process |
26 |
原料クロロゲン酸又は原薬クロロゲン酸とその調製方法及び質量検出方法 Raw Material CHA or Raw Drug Chlorogenic Acid, Method for Preparing the Same and Method for Detecting Mass Thereof |
JP6379286B2 | 2018/8/22 | Preparation Process |
Korea |
||||
27 |
클로로겐산 결정형 및 이의 제조 방법 Crystalline Form of CHA and Preparation Method Thereof |
KR101893964B1 | 2018/8/31 | Preparation Process |